Exploring the Binding Affinity of Novel Syringic Acid Analogues and Critical Determinants of Selectivity as Potent Proteasome Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|16|11|1496-1510

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.16, Iss.11, 2016-10, pp. : 1496-1510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteasome inhibitors in acute leukemia

By Niewerth Denise   Dingjan Ilse   Cloos Jacqueline   Jansen Gerrit   Kaspers Gertjan  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 327-337

Informa Healthcare

Access to resources Recommend Favorite

Proteasome inhibitors in the treatment of multiple myeloma

By McBride Ali   Ryan Patricia Y  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 339-358

Informa Healthcare

Access to resources Recommend Favorite

Proteasome Inhibitors Therapeutic Strategies for Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells

By                

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1824-1832

Spandidos Publications

Access to resources Recommend Favorite

A novel class of tubulin inhibitors that exhibit potent antiproliferation and in vitro vessel-disrupting activity

By Meng Fanying   Cai Xiaohong   Duan Jianxin   Matteucci Mark   Hart Charles  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 953-963

Springer Publishing Company

Access to resources Recommend Favorite